A look at how legislation—and the wider quest for more transparency on drug costs and reimbursement—may impact manufacturer product launch and pricing strategies in the years ahead.Jesse Mendelsohn, senior vice president of Model N, recently spoke with Pharmaceutical Executive on the complicated and changing complexion around drug pricing, access, and reimbursement in healthcare—including emerging hurdles […]
